Trial Profile
Efficacy of mirabegron in the treatment of overactive bladder in patients who have are ineffective to first and second line treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 12 Dec 2015 New trial record